Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Lilly Shifts Gears In China With New Shanghai-based R&D Center

Nov 03 2010

• By PharmAsia News

Related Content

China At Ground Zero In Explosion of New Diabetes Cases; International Federation Now Projects 500 Million Diabetics Worldwide By 2030

Apr 14 2010

Boehringer Ingelheim Opens R&D Center In Shanghai; Sees Sales Growth From Products On NDRL Reimbursement List

Sep 06 2010

Lilly Closes Its Singapore Drug Discovery Center; Is China Discovery Unit In The Works?

Oct 19 2010

Eli Lilly CEO John Lechleiter Rules Out Mega-merger Or Major Push Into Generics, Outlines Strategy Aimed At China's 21st Century Rise In An Interview With PharmAsia News

Apr 22 2010

China's Second-largest CRO Seeks Initial Public Offering In The U.S.

Oct 11 2010

Eli Lilly's China R&D Head Tony Zhang On Looking At The Universe Of Possibilities In China: An Interview With PharmAsia News

Jun 29 2009

More from Archive

More from Scrip

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window